HCA
EW icon

Harbor Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Harbor Capital Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$682K Buy
7,534
+16
+0.2% +$1.34K 0.05% 460
2026
Q1 		$602K Sell
7,518
-1,155
-13% -$95.2K 0.05% 450
2025
Q4 		$739K Sell
8,673
-14
-0.2% -$1.15K 0.06% 383
2025
Q3 		$676K Buy
8,687
+232
+3% +$18.1K 0.05% 402
2025
Q2 		$661K Sell
8,455
-48
-0.6% -$3.58K 0.03% 493
2025
Q1 		$616K Sell
8,503
-2,632
-24% -$188K 0.03% 507
2024
Q4 		$824K Buy
11,135
+273
+3% +$19.1K 0.04% 479
2024
Q3 		$717K Buy
10,862
+56
+0.5% +$4.07K 0.03% 512
2024
Q2 		$998K Buy
10,806
+14
+0.1% +$1.24K 0.08% 358
2024
Q1 		$1.03M Buy
+10,792
New +$907K 0.13% 203

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Harbor Capital Advisors's EW Position: Q2 2026 in Review

Harbor Capital Advisors increased its Edwards Lifesciences (EW) stake by 0.21% in Q2 2026, buying an estimated $1.34K and bringing the position to 7,534 shares worth $682K. The position accounts for 0.05% of the portfolio, ranked #460.

Harbor Capital Advisors first reported a position in EW in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.03M in Q1 2024. 896 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Harbor Capital Advisors held 7,534 shares of Edwards Lifesciences worth $682K as of Q2 2026.
  • Harbor Capital Advisors bought 16 Edwards Lifesciences shares in Q2 2026, an estimated $1.34K.
  • Edwards Lifesciences made up 0.05% of Harbor Capital Advisors's portfolio in Q2 2026, its #460 holding.
  • Harbor Capital Advisors first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's Edwards Lifesciences position peaked at $1.03M in Q1 2024.
  • 896 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.